APA (7th ed.) Citation

KA, H., CL, B., S, D., EJ, D., & SP, M. (2022). Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors. Cancer, 128(12), 2258. https://doi.org/10.1002/cncr.34207

Chicago Style (17th ed.) Citation

KA, Hrebinko, Bryce CL, Downs-Canner S, Diego EJ, and Myers SP. "Cost-effectiveness of Choosing Wisely Guidelines for Axillary Observation in Women Older than Age 70 Years with Hormone Receptor-positive, Clinically Node-negative, Operable Breast Tumors." Cancer 128, no. 12 (2022): 2258. https://doi.org/10.1002/cncr.34207.

MLA (9th ed.) Citation

KA, Hrebinko, et al. "Cost-effectiveness of Choosing Wisely Guidelines for Axillary Observation in Women Older than Age 70 Years with Hormone Receptor-positive, Clinically Node-negative, Operable Breast Tumors." Cancer, vol. 128, no. 12, 2022, p. 2258, https://doi.org/10.1002/cncr.34207.